The promise of continuous manufacturing seems almost limitless in its potential. But, what about the reality on the ground? Louis Garguilo, Chief Editor of Outsourced Pharma, looks at current continuous manufacturing initiatives underway and what’s slowing adoption.
To understand how one company leverages Continuous manufacturing, Garguilo caught up with two continuous manufacturing executives at Novartis. They discuss continuous manufacturing’s role at Novartis how the view it as “a disruptive innovation the likes of which are rarely seen in our industry.” Garguilo than gathers the insights from continuous manufacturing experts from Takeda, Patheon, and Rutgers University. The three share how continuous manufacturing will expand and the factors that will drive it.